Most recently, it has been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to the wide array of endogenous opioids. Not like most opioid receptors, this receptor functions being a scavenger https://davym431toh3.blogcudinti.com/profile